logo
Company

About us

On a mission to bring innovative software solutions to the biomedical field

The ENPICOM dream

We make up a top-class and diverse team of experts, with the right combination of knowledge and expertise to jointly tackle the data analysis and software engineering challenges related to the field of immunomics. Together with our scientific and strategic partners and supported by our investors, we aim to develop tools and validate applications to truly bridge the gap between immune repertoire sequencing and the insights needed to improve the health of patients treated with immunotherapy or affected by immune system related diseases or conditions.

Enpicom

Mission and vision

ENPICOM aims to become the global leader in personalizing immunotherapy with groundbreaking bioinformatics methods and state-of-the-art software to accelerate drug development, and improve patient stratification & treatment monitoring of immunotherapies.

Innovative repertoire sequencing data management, analysis, and visualization will empower biopharma companies and doctors to make the adaptive immune system our strongest weapon in the battle against deadly diseases.

Our culture

Combine the serious business with joy and laugther

Have fun

Going to work with a smile changes everything.

ENPICOM Team members canoeing

Strive for excellence

Excellence is not an exception, it is a prevailing attitude.

Enjoy teamwork

Talent wins games, but teamwork and intelligence win championships.

Be passionate

Passion is energy. Feel the power that comes from focusing on what excites you.

Innovate disruptively

Innovation distinguishes between a leader and a follower.

Embrace diversity

We work in an environment where inclusivity is a priority and everyone’s ideas are valued.

Our people

Wide variety of people coming together

The ENPICOM team

Nicola Bonzanni

Founder & Chief Product Officer

Jos Lunenberg

Founder & Chief Executive Officer

Ted Kloosterman

Head of Commerce

Vadim Galaktionov

Head of Software

Anke Thönissen-Maertens

Head of Operations

Lorenzo Fanchi

Product Management Team Lead

Thijs Maas

Bioinformatics Developer

Pim Fuchs

Bioinformatics Project Lead

Gergana Bounova

Senior Bioinformatics Scientist

Henk-Jan van den Ham

Research Team Lead

Michiel Gielen

Technical Lead

Jorrit Posthuma

Senior Software Engineer

Rickson Muchedzi

Junior SE Consultant

Dimitar Markov

QA Consultant

Lana Lozova

Marketing Communications Manager

Néstor Vázquez Bernat

Application Scientist

Piotr van Rijssel

Application Scientist

Sjors de Waard

Sales Executive

Jelle Pelgrims
Jelle Pelgrims

Solutions Engineer

Talia Santos Corporate images
Talia Santos

Junior AI Engineer

Luis
Luís Alves de Sousa Rêgo

Software Engineer

Klarinda de Zwaan

Application Support Assistant

Robert Rankin

Sales Executive

Levi Lau

Junior Account Manager

Stefan Lelieveld

Bioinformatics Scientist

Rory Matthews

Junior Software Engineer

Steven Liebregt

Junior Software Engineer

Wenying Chang

UX/UI Designer

Stijntje Hibender

Product Manager

Przemysław Nowak

Senior SE Consultant

Mateusz Safaryjski

Junior SE Consultant

Andra Nastase

Junior Marketing Specialist

Yolandi Harmse

Multi-media designer

Scientific advisory board

  • Dr. Eline (Nina) Luning Prak is a Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania. Dr. Luning Prak studies antibody repertoire in health and disease and directs the Human Immunology Core lab at Penn. In addition, Dr. Luning Prak is the current chair of the Executive Sub-committee of the AIRR Community that is establishing data standards for NGS immune repertoire profiling studies.

  • Victor Greiff is an Associate Professor for Computational and Systems Immunology at the University of Oslo. His work focuses specifically on the development of machine learning, computational and experimental tools for the analysis of adaptive immune receptor repertoires to facilitate the in silico design of immune receptor-based immunodiagnostics and immunotherapeutics.

Investors

On March 5, 2019 ENPICOM has closed a series A investment round. BOM Brabant Ventures, Nextgen Ventures and Arches Capital have jointly invested 1.2 million euros to support the company’s repertoire sequencing data analysis platform. 

Press release
Strategic partners
DDL lab

On May 9, 2019 ENPICOM has announced a collaboration with DDL Diagnostic Laboratory, a state-of-the-art laboratory specializing in molecular diagnostic testing and assay development, to jointly deliver immune repertoire sequencing and analysis service.

press release
Biopharma partners

December 4, 2019. Backed by an MIT-Zuid R&D partnership subsidy, the collaboration between ENPICOM and Cytura Therapeutics will take advantage of recent advances in bioinformatics and machine learning to develop a new biomarker and diagnostic assay for early cancer detection.

Press release
Glycostem logo

December 8, 2018. Glycostem and ENPICOM receive MIT Zuid subsidy to support their R&D partnership project aiming to develop technology to predict the outcome of NK-cell-based immunotherapy treatment in patients with incurable locally advanced or metastatic solid tumors.

Press release

July 5, 2018. A total grant sum of EUR 2 million has been awarded to a multidisciplinary EUROSTARS consortium. The project is titled “Treatment Response Monitoring for Cancer Immunotherapies Using Immune Repertoire Analysis” and named IMMUNOMONITOR.

Press release

July 5, 2018. A total grant sum of EUR 2 million has been awarded to a multidisciplinary EUROSTARS consortium. The project is titled “Treatment Response Monitoring for Cancer Immunotherapies Using Immune Repertoire Analysis” and named IMMUNOMONITOR.

Press release

logo
Academic partners